Invesco Ltd. Adma Biologics, Inc. Transaction History
Invesco Ltd.
- $516 Billion
- Q4 2024
A detailed history of Invesco Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 11,296,255 shares of ADMA stock, worth $272 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,296,255
Previous 12,619,769
10.49%
Holding current value
$272 Million
Previous $252 Million
23.2%
% of portfolio
0.04%
Previous 0.05%
Shares
21 transactions
Others Institutions Holding ADMA
# of Institutions
351Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$450 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$439 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$359 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.53MShares$133 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.43MShares$131 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.73B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...